AN2 Therapeutics, Inc. (ANTX)
4.55
+0.07
(+1.56%)
USD |
NASDAQ |
May 19, 16:00
4.50
-0.05
(-1.10%)
After-Hours: 20:00
AN2 Therapeutics EPS Diluted (TTM) : -1.104 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Relmada Therapeutics, Inc. | -1.112 |
| Corcept Therapeutics, Inc. | 0.35 |
| Assertio Holdings, Inc. | -5.733 |
| Johnson & Johnson | 8.649 |
| Eli Lilly & Co. | 27.78 |